-transparent.png){kind=logo}
An increasing focus on the mechanism of synaptic neurochemistry in pediatric neurology, may lead to a better understanding of the pathophysiology of many disorders and result in a more rational approach to their pharmacotherapy. With the burgeoning list of putative neurotransmitters in brain, and the growing evidence of co-localization of many of these neurotransmitters, chemical neurotransmission likely involves a higher degree of complexity than appreciated heretofore. The potential role of neurotransmitter dysfunction in the pathophysiology of neurologic and behavior disorders of children, should not be considered as restricted to those disorders that involve selective neuronal loss, but may encompass a much wider spectrum of syndromes due to metabolic abnormalities, as well as disturbances of the finer features of chemical neurotransmission.
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
January 1981,
Ciba Foundation symposium,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
January 2022,
Metabolic brain disease,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
December 2002,
Dialogues in clinical neuroscience,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
January 1994,
Fundamental & clinical pharmacology,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
May 2007,
Journal of child neurology,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
March 2023,
Research square,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
February 2014,
Journal of Crohn's & colitis,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
June 2014,
Journal of child psychology and psychiatry, and allied disciplines,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
January 2004,
Neuroscience letters,
J T Coyle, and
H Singer, and
M Beaulieu, and
M V Johnston
May 2000,
Neuroscience letters,
